European Archives - Page 64 of 1318 - European Medical Journal

The latest issue of EMJ Cardiology

Featuring unmissable insights from the ESC Congress 2025. Inside, discover the latest in cardiology news and breakthroughs, including an…

UEG Week 2025: Semaglutide Improves MASH Histology Through Weight-Independent Mechanisms

New ESSENCE trial data show semaglutide improves liver histology and non-invasive markers in MASH through mechanisms beyond weight loss, highlighting dual metabolic benefits.

UEG Week 2025: Europe Faces Rising Liver Cancer Epidemic

New joint statement from United European Gastroenterology and the German Society for Gastroenterology calls for coordinated prevention, early detection, and policy reform to reverse the rising tide of liver cancer across Europe.

Explainable AI and Chatbot-Enabled ACS Mortality Prediction in Asian Populations

ST-elevation myocardial infarction (STEMI) is a leading cause of mortality, with significant variations in risk profiles among the Asian…

Review of the European Society of Cardiology (ESC) Congress 2025

With three-quarters of a century dedicated to advancing cardiovascular science and improving patient care, the ESC President…

EMJ Cardiology 13.1 2025

Inside, you will find a variety of content, including our in-depth review of the European Society of Cardiology (ESC) Congress 2025…

MAPLE-HCM: Aficamten vs Metoprolol in Obstructive HCM

Beta-blockers have been the cornerstone of treatment for obstructive hypertrophic cardiomyopathy for almost 6 years. Recent data from…

SGLT2 Inhibitors in Heart Failure: Why the Elderly are Missing Out

Heart failure (HF) constitutes a significant disease burden in the USA. Its prevalence has doubled between 1990–2020, showing an increase…

Association Between the Frequency of Laughter, Cardiovascular Event Risk, and Quality of Life

Negative emotions, particularly depression, are known to increase cardiovascular disease risk and reduce quality of life (QOL). By …

What’s New in Heart Failure? Highlights and Insights from ESC 2025

The DIGIT-HF trial1 demonstrated that digoxin lowered hospitalisation for HF, but not mortality. As a result of this…